Frontlight ResearchEarly access
TerminatedNo phase
Diffusion Weighted Magnetic Resonance Imaging and the Optic Nerve Neuropathy.
Key facts
- Who runs it
- Medical University of Bialystok
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 7 people enrolled
- Started
- 1 Jan 2020
- Ended
- 6 Mar 2026
- Type of study
- Interventional, 2 groups
- Treatments tested
- Neuroimaging
- VEP - visual evoked potential
- Ophthalmology examination.
- Record updated
- 23 October 2026
- Why it stopped
- Study terminated prematurely due to lack of funding. Seven patients with optic neuropathies were enrolled; no healthy volunteers were enrolled.
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Patient group: optic neuropathy
- Planned healthy control group: healthy volunteers without concomitant diseases
Who cannot take part
- Common contraindications to MRI (presence of pacemaker, non-MRI-safety or claustrophobia)
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of the project is to create a new, non-invasive and safe protocol for the early diagnosis of various types of optic neuropathies with the use of diffusion magnetic resonance imaging
The 2 groups in the trial
- Various types of optic neuropathiesTreatment being tested
Patients with various types of optic neuropathy.
Treatment: Neuroimaging, VEP - visual evoked potential, and Ophthalmology examination.
- Healthy volunteersOther group
Treatment: Neuroimaging, VEP - visual evoked potential, and Ophthalmology examination.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 23 October 2026